- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.11 Å
- Oligo State
- homo-trimer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 21 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-MAN.2: 4 residues within 4Å:- Chain A: N.122, A.123, T.124, E.169
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.4: 7 residues within 4Å:- Chain A: T.108, N.234, T.236
- Chain B: R.454, S.456, N.457, K.459
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.5: 3 residues within 4Å:- Chain A: N.277, E.278, N.279
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.7: 4 residues within 4Å:- Chain A: N.714, L.919, Q.923, Q.1068
1 PLIP interactions:1 interactions with chain A- Hydrophobic interactions: A:L.919
NAG-NAG-MAN.8: 3 residues within 4Å:- Chain A: N.798, S.800, Q.801
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.10: 4 residues within 4Å:- Chain A: N.1095, T.1097, H.1098, F.1100
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.11: 1 residues within 4Å:- Chain A: N.1131
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.13: 3 residues within 4Å:- Chain B: N.122, T.124, N.125
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.15: 7 residues within 4Å:- Chain B: T.108, N.234, T.236
- Chain C: R.454, K.455, S.456, K.459
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.16: 3 residues within 4Å:- Chain B: N.277, E.278, N.279
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.18: 4 residues within 4Å:- Chain B: N.714, L.919, Q.923, Q.1068
1 PLIP interactions:1 interactions with chain B- Hydrophobic interactions: B:L.919
NAG-NAG-MAN.19: 3 residues within 4Å:- Chain B: N.798, S.800, Q.801
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.21: 4 residues within 4Å:- Chain B: N.1095, T.1097, H.1098, F.1100
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.22: 1 residues within 4Å:- Chain B: N.1131
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.24: 2 residues within 4Å:- Chain C: N.122, T.124
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.26: 9 residues within 4Å:- Chain A: R.454, K.455, S.456, N.457, L.458, K.459
- Chain C: T.108, N.234, T.236
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.27: 3 residues within 4Å:- Chain C: N.277, E.278, N.279
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.29: 4 residues within 4Å:- Chain C: N.714, L.919, Q.923, Q.1068
1 PLIP interactions:1 interactions with chain C- Hydrophobic interactions: C:L.919
NAG-NAG-MAN.30: 3 residues within 4Å:- Chain C: N.798, S.800, Q.801
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.32: 4 residues within 4Å:- Chain C: N.1095, T.1097, H.1098, F.1100
No protein-ligand interaction detected (PLIP)NAG-NAG-MAN.33: 1 residues within 4Å:- Chain C: N.1131
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-FUC.9: 3 residues within 4Å:- Chain A: A.703, E.1069, N.1071
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.20: 3 residues within 4Å:- Chain B: A.703, E.1069, N.1071
No protein-ligand interaction detected (PLIP)NAG-NAG-FUC.31: 3 residues within 4Å:- Chain C: A.703, E.1069, N.1071
No protein-ligand interaction detected (PLIP)- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.34: 2 residues within 4Å:- Chain A: Y.28, N.61
Ligand excluded by PLIPNAG.35: 3 residues within 4Å:- Chain A: K.147, N.148, N.149
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain A: N.328, Q.577
Ligand excluded by PLIPNAG.37: 3 residues within 4Å:- Chain A: F.335, G.336, N.340
Ligand excluded by PLIPNAG.38: 1 residues within 4Å:- Chain A: N.600
Ligand excluded by PLIPNAG.39: 2 residues within 4Å:- Chain A: H.652, N.654
Ligand excluded by PLIPNAG.40: 2 residues within 4Å:- Chain A: N.706, G.1128
Ligand excluded by PLIPNAG.41: 1 residues within 4Å:- Chain A: N.1155
Ligand excluded by PLIPNAG.42: 2 residues within 4Å:- Chain B: Y.28, N.61
Ligand excluded by PLIPNAG.43: 3 residues within 4Å:- Chain B: K.147, N.148, N.149
Ligand excluded by PLIPNAG.44: 2 residues within 4Å:- Chain B: N.328, Q.577
Ligand excluded by PLIPNAG.45: 3 residues within 4Å:- Chain B: G.336, N.340, L.365
Ligand excluded by PLIPNAG.46: 1 residues within 4Å:- Chain B: N.600
Ligand excluded by PLIPNAG.47: 2 residues within 4Å:- Chain B: H.652, N.654
Ligand excluded by PLIPNAG.48: 3 residues within 4Å:- Chain A: D.793
- Chain B: N.706, G.1128
Ligand excluded by PLIPNAG.49: 1 residues within 4Å:- Chain B: N.1155
Ligand excluded by PLIPNAG.50: 2 residues within 4Å:- Chain C: Y.28, N.61
Ligand excluded by PLIPNAG.51: 3 residues within 4Å:- Chain C: K.147, N.148, N.149
Ligand excluded by PLIPNAG.52: 2 residues within 4Å:- Chain C: N.328, Q.577
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain C: F.335, G.336, N.340
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain C: N.600
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain C: H.652, N.654
Ligand excluded by PLIPNAG.56: 3 residues within 4Å:- Chain B: D.793
- Chain C: N.706, G.1128
Ligand excluded by PLIPNAG.57: 1 residues within 4Å:- Chain C: N.1155
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cai, Y. et al., Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. Science (2021)
- Release Date
- 2021-07-07
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY 3.11 Å
- Oligo State
- homo-trimer
- Ligands
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 21 x NAG- NAG- MAN: alpha-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- FUC: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-[alpha-L-fucopyranose-(1-6)]2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Cai, Y. et al., Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variants. Science (2021)
- Release Date
- 2021-07-07
- Peptides
- Spike glycoprotein: ABC
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
C